Objectives:

to evaluate the effect of the consumption of the Natural Nutraceutical product based on Amaranth (Amaranthus caudatus), Quinoa (Chenopodium quinoa), and Tarwi (Lupinus mutabilis) (AQT) on serum levels of sodium, potassium, and uric acid as indicators for achieving homeostasis in patients with type 2 diabetes mellitus, overweight, and hypertension.

Methods:

this study is a preliminary, controlled, quantitative, randomized, prospective clinical trial conducted in parallel with the research project on medicinal properties of natural nutraceutical products as treatment for diabetes and/or overweight in the cities of La Paz and El Alto, phase 2 in the year 2019.

Results:

Patients with type 2 diabetes mellitus exhibited significantly higher serum levels of uric acid compared to the control group (*p<0.05; 95% confidence). However, after the consumption of the AQT nutraceutical, no significant alterations were observed in blood levels of sodium and potassium. In contrast, serum levels of uric acid decreased, suggesting an improvement in its homeostasis.

Conclusions:

The consumption of the AQT product does not generate adverse effects on serum levels of sodium, potassium, and uric acid, as none of these levels increased or decreased in patients with type 2 diabetes, overweight, and hypertension.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )